Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Medicines With The Active Ingredient Adalimumab (atc: L04ab04) 2026-03-16
Germany Medicines With The Active Ingredient Vareniclin (atc 2026-03-16
Germany Completion Of A Non-exclusive Discount Agreement According To Section 130a (8) Sgb V For The Active Ingredient Iron (parenteral Preparations), Atc B03ac02 F. D. Z. 01.11.25-31.10.27 (plus Extension Option 1x12 Month) 2026-03-16
Germany Open House Pharmaceutical Discounts On The Active Ingredient Ethosuximide, Atc N03ad01, 67304 Eisenberg Rhineland-palatinate 2026-03-16
Germany Open House Pharmaceutical Discounts On The Active Ingredient Clonidine, Atc C02ac01, 67304 Eisenberg Rhineland-palatinate 2026-03-16
Germany Open House Pharmaceutical Discount Contracts For The Active Ingredient Tamoxifen, Atc L02ba01, 67304 Eisenberg Rhineland-palatinate 2026-03-16
Germany Open House Pharmaceutical Discount Contracts For The Active Ingredient Tamoxifen, Atc L02ba01, 67304 Eisenberg Rhineland-palatinate 2026-03-16
Germany Open House Pharmaceutical Discounts On The Active Ingredient Clonidine, Atc C02ac01, 67304 Eisenberg Rhineland-palatinate 2026-03-16
Germany Open House Pharmaceutical Department Treats To The Active Ingredient Clomipramin, Atc N06aa04, 67304 Eisenberg Rhineland-palatinate 2026-03-16
Germany Open House Pharmaceutical Discounts On The Active Ingredient Ethosuximide, Atc N03ad01, 67304 Eisenberg Rhineland-palatinate 2026-03-16
Whats app